390 related articles for article (PubMed ID: 35211017)
1. Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect.
Huang J; Wu R; Chen L; Yang Z; Yan D; Li M
Front Pharmacol; 2022; 13():811406. PubMed ID: 35211017
[TBL] [Abstract][Full Text] [Related]
2. The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside.
Li Y; Lin R; Peng X; Wang X; Liu X; Li L; Bai R; Wen S; Ruan Y; Chang X; Tang R; Liu N
Oxid Med Cell Longev; 2022; 2022():3659278. PubMed ID: 36187332
[TBL] [Abstract][Full Text] [Related]
3. New signal transduction paradigms in anthracycline-induced cardiotoxicity.
Ghigo A; Li M; Hirsch E
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Aspects of Anthracycline Cardiotoxicity.
Russo M; Della Sala A; Tocchetti CG; Porporato PE; Ghigo A
Curr Treat Options Oncol; 2021 Feb; 22(2):18. PubMed ID: 33547494
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
Murabito A; Hirsch E; Ghigo A
Front Cardiovasc Med; 2020; 7():35. PubMed ID: 32226791
[TBL] [Abstract][Full Text] [Related]
6. Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies.
Wang T; Xing G; Fu T; Ma Y; Wang Q; Zhang S; Chang X; Tong Y
Int J Med Sci; 2024; 21(5):809-816. PubMed ID: 38617011
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging.
Jong J; Pinney JR; Packard RRS
Front Cardiovasc Med; 2022; 9():919719. PubMed ID: 35990941
[TBL] [Abstract][Full Text] [Related]
8. Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine.
Cheah IK; Tang RMY; Wang X; Sachaphibulkij K; Chong SY; Lim LHK; Wang JW; Halliwell B
Antioxidants (Basel); 2023 Jan; 12(2):. PubMed ID: 36829879
[No Abstract] [Full Text] [Related]
9. Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions.
Osataphan N; Phrommintikul A; Chattipakorn SC; Chattipakorn N
J Cell Mol Med; 2020 Jun; 24(12):6534-6557. PubMed ID: 32336039
[TBL] [Abstract][Full Text] [Related]
10. Anthracycline Cardiotoxicity: It Is Possible to Teach an Old Dog Some New Tricks.
Alvarez-Cardona J; Lenihan DJ
Cardiol Clin; 2019 Nov; 37(4):355-363. PubMed ID: 31587778
[TBL] [Abstract][Full Text] [Related]
11. Signaling Pathways Underlying Anthracycline Cardiotoxicity.
Sala V; Della Sala A; Hirsch E; Ghigo A
Antioxid Redox Signal; 2020 May; 32(15):1098-1114. PubMed ID: 31989842
[No Abstract] [Full Text] [Related]
12. The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity.
Russo M; Bono E; Ghigo A
Curr Heart Fail Rep; 2021 Aug; 18(4):180-190. PubMed ID: 34081265
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
He L; Liu F; Li J
Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation.
Rocca C; Pasqua T; Cerra MC; Angelone T
Antioxid Redox Signal; 2020 May; 32(15):1081-1097. PubMed ID: 31928066
[No Abstract] [Full Text] [Related]
15. The role of iron in anthracycline cardiotoxicity.
Gammella E; Maccarinelli F; Buratti P; Recalcati S; Cairo G
Front Pharmacol; 2014; 5():25. PubMed ID: 24616701
[TBL] [Abstract][Full Text] [Related]
16. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.
Chung WB; Youn HJ
Korean J Intern Med; 2016 Jul; 31(4):625-33. PubMed ID: 27378126
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Placebo Arms From Randomized Controlled Trials.
Jeyaprakash P; Sangha S; Ellenberger K; Sivapathan S; Pathan F; Negishi K
J Am Heart Assoc; 2021 Mar; 10(6):e018802. PubMed ID: 33660514
[TBL] [Abstract][Full Text] [Related]
19. Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments.
Zhang G; Yuan C; Su X; Zhang J; Gokulnath P; Vulugundam G; Li G; Yang X; An N; Liu C; Sun W; Chen H; Wu M; Sun S; Xing Y
Front Cardiovasc Med; 2022; 9():896792. PubMed ID: 35770215
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline degradation in cardiomyocytes: a journey to oxidative survival.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2010 Jan; 23(1):6-10. PubMed ID: 19954191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
